ASG vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and an absent Altman Z-Score, preventing a full distress risk assessment. Despite a low P/E of 9.54 compared to the sector average of 21.57 and a Price/Book of 0.90 suggesting possible value appeal, the company faces severe operational challenges, including negative operating margin (-125.62%) and steep year-over-year declines in revenue (-13.20%) and earnings (-80.60%). The high dividend yield of 8.94% appears unsustainable given the 82.14% payout ratio amid falling earnings, while technical indicators signal a bearish trend. Although the stock trades above the Graham Number of $8.64, current price of $5.34 appears misleadingly low due to deteriorating fundamentals and lack of analyst coverage.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
ASG vs JPM: Head-to-Head Comparison
This page compares Liberty All-Star Growth Fund, Inc. (ASG) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.